126 related articles for article (PubMed ID: 2482056)
1. Enhanced plasma and intracellular levels of main granulocyte components in diabetics on dialysis.
Hörl WH; Schaefer RM; Wanner C; Bahlmann J; Reitinger J; Schollmeyer P; Heidland A
Blood Purif; 1989; 7(6):314-23. PubMed ID: 2482056
[TBL] [Abstract][Full Text] [Related]
2. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.
Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S
Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of main granulocyte components during hemodialysis: effects of immunosuppression.
Riegel W; Leverenz K; Schollmeyer P; Wilms H; Hörl WH
Nephron; 1987; 46(2):161-6. PubMed ID: 3037400
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of main granulocyte components during cardiopulmonary bypass.
Riegel W; Spillner G; Schlosser V; Hörl WH
J Thorac Cardiovasc Surg; 1988 Jun; 95(6):1014-9. PubMed ID: 2836662
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers.
Hörl WH; Feinstein EI; Wanner C; Frischmuth N; Gösele A; Massry SG
Am J Nephrol; 1990; 10(1):53-7. PubMed ID: 2343881
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes.
Hörl WH; Riegel W; Schollmeyer P
Nephron; 1987; 45(4):272-6. PubMed ID: 3035392
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of main granulocyte components during hemodialysis.
Hörl WH; Riegel W; Steinhauer HB; Wanner C; Schollmeyer P; Schaefer RM; Heidland A
Contrib Nephrol; 1987; 59():35-43. PubMed ID: 2832120
[No Abstract] [Full Text] [Related]
8. Evidence for the participation of granulocyte proteinases on intradialytic catabolism.
Hörl WH; Heidland A
Clin Nephrol; 1984 Jun; 21(6):314-22. PubMed ID: 6205803
[TBL] [Abstract][Full Text] [Related]
9. Beta-2-microglobulin and main granulocyte components in hemodialysis patients.
Haag-Weber M; Schollmeyer P; Hörl WH
Artif Organs; 1989 Apr; 13(2):92-6. PubMed ID: 2650660
[TBL] [Abstract][Full Text] [Related]
10. Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis.
Hörl WH; Schaefer RM; Heidland A
Am J Nephrol; 1985; 5(5):320-6. PubMed ID: 2414989
[TBL] [Abstract][Full Text] [Related]
11. Augmented release of human leucocyte lactoferrin (and elastase) during coagulation.
Adeyemi EO; Hodgson HJ
J Clin Lab Immunol; 1988 Sep; 27(1):1-4. PubMed ID: 3266944
[TBL] [Abstract][Full Text] [Related]
12. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
Nuijens JH; Abbink JJ; Wachtfogel YT; Colman RW; Eerenberg AJ; Dors D; Kamp AJ; Strack van Schijndel RJ; Thijs LG; Hack CE
J Lab Clin Med; 1992 Feb; 119(2):159-68. PubMed ID: 1740629
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte lysosomal factors and plasma elastase in uremia: a potential factor of catabolism.
Heidland A; Hörl WH; Heller N; Heine H; Neumann S; Schaefer RM; Heidbreder E
Klin Wochenschr; 1984 Mar; 62(5):218-24. PubMed ID: 6201647
[TBL] [Abstract][Full Text] [Related]
14. Within-subject variation of elastase/alpha 1-protease inhibitor complexes and lactoferrin in plasma.
Antonsen S
Scand J Clin Lab Invest; 1993 Oct; 53(6):611-6. PubMed ID: 8266008
[TBL] [Abstract][Full Text] [Related]
15. [Flowcytomeric analysis on neutrophil intracellular enzyme activity in patients on hemodialysis and continuous ambulatory peritoneal dialysis].
Otsubo H; Kaito K; Shiba K
Kansenshogaku Zasshi; 2000 Jan; 74(1):73-81. PubMed ID: 10695298
[TBL] [Abstract][Full Text] [Related]
16. Hemodialysis-induced increase in serum lactoferrin and serum eosinophil cationic protein as signs of local neutrophil and eosinophil degranulation.
Hällgren R; Venge P; Wikström B
Nephron; 1981; 29(5-6):233-8. PubMed ID: 7322251
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients.
Costa E; Rocha S; Rocha-Pereira P; Nascimento H; Castro E; Miranda V; Faria Mdo S; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
Am J Nephrol; 2008; 28(6):935-40. PubMed ID: 18587235
[TBL] [Abstract][Full Text] [Related]
18. Angiogenin: a novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation.
Schmaldienst S; Oberpichler A; Tschesche H; Hörl WH
Kidney Blood Press Res; 2003; 26(2):107-12. PubMed ID: 12771535
[TBL] [Abstract][Full Text] [Related]
19. Serum and plasma myeloperoxidase, elastase and lactoferrin content in acute myeloid leukaemia.
Olsson I; Olofsson T; Ohlsson K; Gustavsson A
Scand J Haematol; 1979 May; 22(5):397-406. PubMed ID: 224448
[TBL] [Abstract][Full Text] [Related]
20. [Continuous ambulatory peritoneal dialysis in diabetic patients].
Stojimrović B; Nesić V
Srp Arh Celok Lek; 1998; 126(7-8):277-82. PubMed ID: 9863395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
